Share these talks and lectures with your colleagues
Invite colleaguesWe noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login
or review methods of
obtaining more access.
Printable Handouts
Navigable Slide Index
- Introduction
- Reaven’s syndrome X
- Coronary heart disease (CHD) odds ratio
- Our "toxic" lifestyle
- Landscape change in modifiable CVD risk factors
- An early finding from our lab
- Visceral obesity and metabolic abnormalities
- Risk of ischemic heart disease (IHD)
- Insulin resistance
- Simple screening tool to find insulin resistance
- Clinical identification of the metabolic syndrome
- 2009 harmonized definition of the syndrome
- Relative risks and the metabolic syndrome
- Metabolic syndrome: some issues
- Distinctions of metabolic abnormalities
- Non-obese individuals metabolic syndrome
- Waist girth among and metabolic syndrome
- Abdominal obesity and metabolic syndrome (1)
- Abdominal obesity and metabolic syndrome (2)
- Excess liver fat
- Liver fat and visceral fat: cardiometabolic risk link
- Liver fat content measurement
- Sex differences in liver fat content
- Excess visceral adiposity/liver fat data
- Visceral adipose tissue and cardiometabolic risk
- Overall objectives of INSPIRE ME IAA
- General information: INSPIRE ME IAA
- Visceral adipose tissue measurement
- Liver fat measurement (Th12-L1)
- Cardiometabolic risk
- Categorization by T2D and tertiles of VAT
- Triglyceride concentrations in men
- Triglyceride concentrations in women
- HDL cholesterol concentrations in men
- HDL cholesterol concentrations in women
- Inflammatory factors, visceral adiposity & T2D
- Liver fat, visceral adiposity & T2D
- Frequency of prevalent CVD
- Type 2 diabetes odds ratios
- Conclusion about excess visceral adiposity/liver
- Excess visceral/liver fat and high risk obesity
- Visceral obesity=dysfunctional adipose tissue?
- Visceral obesity/ectopic fat screening tool
- Hypertriglyceridemic waist
- HyperTG waist and CHD risk study
- HyperTG waist in men
- HyperTG waist in women
- Survival of hyperTG waist subgroups in men
- Survival of hyperTG waist subgroups in women
- Clinical diagnosis limitations
- Comparing CHD risk in two cases
- CHD risk associated with metabolic syndrome
- Metabolic syndrome: a component of global CMR
- Visceral adiposity/ectopic fat in risk assessment
- Management of patients with metabolic syndrome
- "Turbostatins"
- The abdominally obese patient
- More from the EPIC-Norfolk study
- CHD event rate and physical activity
- Low cardiorespiratory fitness: CHD risk factor
- Cardiorespiratory fitness predicts mortality
- Reshaping lifestyle habits of obese patients
- The “metabolic syndrome”: summary
Topics Covered
- Reaven’s syndrome X
- Coronary heart disease (CHD) and type 2 diabetes odds ratio
- Our "toxic" lifestyle
- Landscape change in modifiable CVD risk factors
- Risk of ischemic heart disease (IHD)
- Insulin resistance
- The metabolic syndrome: distinctions of metabolic abnormalities, CHD risk, non-obese individuals, waist girth, abdominal obesity and management,- Liver fat and visceral fat: cardiometabolic risk link
- Sex differences in liver fat content
- Overall objectives of INSPIRE ME IAA
- Categorization by T2D and tertiles of VAT
- Triglyceride & HDL cholesterol concentrations in men & women
- Inflammatory factors, liver fat, visceral adiposity & T2D
- Frequency of prevalent CVD
- Visceral obesity/ectopic fat screening tool
- HyperTG waist survival and CHD risk study
- Clinical diagnosis limitations
- "Turbostatins”
- The EPIC-Norfolk study
- CHD event rate and physical activity
- Reshaping lifestyle habits of obese patients
Links
Series:
Categories:
Therapeutic Areas:
Talk Citation
Després, J.P. (2013, May 22). The metabolic syndrome [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved January 23, 2021, from https://hstalks.com/bs/2547/.Publication History
Financial Disclosures
- Prof. Jean Pierre Després, Consultant: Novartis, Thera technologies, Torrent Pharma ; Speaker’s Bureau: Abbot, Astra Zeneca, GSK, Pfizer, Merck.
The metabolic syndrome
Published on May 22, 2013
61 min